NCT01670019 - Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions

Major Depressive Disorder Without Psychotic Features

Interventions

DRUG

Asenapine 5-20 mg daily

5 mg QHS, or 5 mg BID, or 5 mg QAM and 10 mg QHS, or 10 mg BID

DRUG

Placebo 1-4 tablets daily

One placebo tablet QHS, or one placebo tablet BID, or one placebo tablet QAM and two placebo tablets QHS, or two placebo tablets BID

Trial Locations (5)

North Carolina Psychiatric Research Center, Raleigh

Carolina Behavioral Care, Durham

Duke University Medical Center, Durham

Brody School of Medicine at East Carolina University, Greenville

Georgia Health Sciences University, Augusta